FDA-Inspected Site

Allergan Sales, LLC

26 FDA inspections are on record for Allergan Sales, LLC in Irvine, United States.

483· Form 483 issued

Irvine, United States · Last updated July 10, 2026

Overview

  • 26 FDA inspections are on record.
  • 8 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-11-07.

At a glance

Inspections

26

Form 483s

8

EIRs

10

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
27 Oct 2025 – 7 Nov 2025Human Drugs483On file
16 Sep 2025 – 19 Sep 2025Medical Devices & Rad HealthClean
24 Oct 2023 – 26 Oct 2023Human DrugsClean
24 Jul 2023 – 28 Jul 2023Human DrugsClean
14 Jan 2019 – 22 Jan 2019Medical Devices & Rad HealthClean
19 Oct 2016Medical Devices & Rad HealthClean
13 Sep 2016 – 20 Sep 2016Human DrugsClean
11 Jan 2016 – 15 Jan 2016Human Drugs483View 483 →
23 Nov 2015 – 7 Dec 2015Medical Devices & Rad HealthClean
1 Apr 2014 – 15 Apr 2014Human Drugs483On file
12 Dec 2013 – 23 Dec 2013Human DrugsClean
1 Apr 2013 – 2 Apr 2013Medical Devices & Rad HealthClean

Observations on record

Form 483 observations cited at this site, most recent first.

15 Jan 2016
21 CFR 211.192

Written record of investigation incomplete

Cited by William J Leonard, Theresa Kirkham

15 Jan 2016
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by William J Leonard, Theresa Kirkham

15 Jan 2016
21 CFR 314.80(c)(1)(i)

Late submission of 15-day report

Cited by William J Leonard, Theresa Kirkham

9 Jul 2010
21 CFR 314.80(c)(1)(i)

Late submission of 15-day report

Cited by Binh T Nguyen

9 Jul 2010
21 CFR 314.80(c)(2)

Late submission of annual safety reports

Cited by Binh T Nguyen

Investigators

FDA investigators tied to this site in the record.

Vickie L Anderson2 insp.
Joao A Pedras Vasconcel1 insp.
Priscilla A Amador Do Amaral1 insp.
Md Kamal Hossain1 insp.
Lan T Tran1 insp.
Ka L Wong1 insp.
Vashti E Bocker1 insp.
Linda Thai1 insp.
Amir Alavi1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 314.80(c)(1)(i)Cited across public-safe Form 483 observations2x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 314.80(c)(2)Cited across public-safe Form 483 observations1x
21 CFR 314.81(b)(2)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Allergan Sales, LLC's 8 Form 483s

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat